Editorial - High dose intravenous immunoglobulins as a therapeutic option for COVID-19 patients
- PMID: 32432784
- DOI: 10.26355/eurrev_202005_21214
Editorial - High dose intravenous immunoglobulins as a therapeutic option for COVID-19 patients
Comment on
-
Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?Lancet Neurol. 2020 May;19(5):383-384. doi: 10.1016/S1474-4422(20)30109-5. Epub 2020 Apr 1. Lancet Neurol. 2020. PMID: 32246917 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
